JAIME ALAYO VILLALOBOS: Open Payments
NPI 1144864620 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 104 payments from 21 companies in 2025. Trend: 2023 $1,334 · 2024 $1,409 · 2025 $1,962
Food & beverage: $1,945Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $266 |
| Novo Nordisk Inc | 13 | $234 |
| Lilly USA, LLC | 12 | $173 |
| Amgen Inc. | 14 | $156 |
| Aimmune Therapeutics, Inc. | 7 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $121 |
| Corcept Therapeutics | 5 | $121 |
| PFIZER INC. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $84 |
| Phathom Pharmaceuticals, Inc. | 4 | $79 |
Products named: MOUNJARO, ZENPEP, Kerendia, Korlym, OTEZLA, Ozempic, FARXIGA, VOQUEZNA.
Industry payments across FL — which companies pay providers there.
